secwatch.observer — SEC 8-K summary
======================================

Issuer:     Enliven Therapeutics, Inc. (ELVN)
CIK:        0001672619
Form:       8-K
Filed at:   2022-06-03T23:59:59+00:00
Accession:  0001564590-22-022471
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Imara Inc. reports annual meeting results; elects directors, ratifies EY as auditor
--------------------------------------------------------------------------------

- Stockholders elected Rahul D. Ballal and Barbara J. Dalton as Class II directors for three-year terms expiring 2025.
- Ballal received 11,789,401 votes for and 1,791,276 withheld; Dalton had 11,786,912 for and 1,793,765 withheld.
- Ratification of Ernst & Young as independent auditor for FY 2022 passed with 18,806,373 votes for, 60,227 against, 46,749 abstentions.
- Meeting held on June 2, 2022; broker non-votes on director elections totaled 5,332,673.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1672619/000156459022022471/0001564590-22-022471-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1672619/000156459022022471/imra-8k_20220602.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-022471

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer